Join our Newsletter
From medical white papers to invite only networking, join our newsletter to stay connected with the world of CRC.
At CRC, Quality Assurance is the foundation of our clinical research philosophy. Our entire organization regards quality as a dynamic, strategic discipline: predictive rather than reactive, integrative rather than siloed. Anchored in a rigorous, risk-based, and neuroscience-optimized Quality Management System (QMS), our approach exceeds regulatory compliance to foster a culture of rigor, transparency, and ethical accountability, ensuring that every study we conduct withstands regulatory scrutiny and earns the trust of investigators and sponsors.
Our QMS is designed to address the scientific and operational nuances of CNS trials, including subjectivity in endpoints, variability in rater performance, and the inclusion of vulnerable populations. CRC applies proportional and flexible controls that align with the therapeutic and clinical goals of each study.
CRC applies QbD principles from study planning through execution, enabling early risk identification and integrated mitigation strategies, which are essential for complex CNS programs.
CRC ensures consistent data integrity and participant safety. Our QMS includes specialized controls for cognitive, behavioral, and psychiatric assessments and aligns with regulatory expectations.
In 2025, a pre-approval FDA inspection of a sponsor and four investigational sites, where we provided rater training, project management, monitoring, and data management, concluded with no Form 483 observations. This outcome reflects our consistent regulatory excellence. Additionally, an FDA inspection of CRC in 2017 resulted in no observations, confirming our longstanding commitment to quality and compliance in CNS clinical research.
CRC provides a comprehensive suite of Quality Assurance services that support inspection readiness and program integrity across every phase of a CNS trial.
Comprehensive evaluations to ensure vendors meet both regulatory and therapeutic expectations.
Thorough reviews of site conduct, documentation, and participant safety, with emphasis on challenges specific to CNS trials.
Strategic consulting to help sponsors design or refine QMS frameworks that reflect the scientific and operational complexity of neuroscience studies.
Preparation and real-time support during regulatory inspections, with a focus on CNS-specific documentation, data integrity, and compliance.
Validation of electronic systems, e.g., eCOA, EDC, and IRT.
From medical white papers to invite only networking, join our newsletter to stay connected with the world of CRC.